UBS AM’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.94K Buy
+295
New +$1.37K ﹤0.01% 4050
2013
Q4
– Sell
-18,399
Closed -$224K – 2549
2013
Q3
$224K Hold
18,399
– – ﹤0.01% 2273
2013
Q2
$243K Buy
+18,399
New +$254K ﹤0.01% 2149

Other funds holding LFCR

UBS AM's LFCR Position: Q3 2026 in Review

UBS AM opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 295 shares worth $1.94K. The stake represents ﹤0.01% of the portfolio and ranks #4050 among its holdings. This is a return to the name: UBS AM previously reported a position in LFCR as recently as Q3 2013.

UBS AM first reported a position in LFCR in Q2 2013 and has held it in 3 quarters since. The position peaked at $243K in Q2 2013. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • UBS AM held 295 shares of Lifecore Biomedical worth $1.94K as of Q3 2026.
  • Lifecore Biomedical was a new UBS AM position in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4050 holding.
  • UBS AM first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 3 quarters since.
  • UBS AM's Lifecore Biomedical position peaked at $243K in Q2 2013.
  • 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.